The firms will collaborate on two lead programs and up to five future targets in other diseases, with NanoVation eligible for up to $600 million in payments from Novo Nordisk.
NanoVation Therapeutics, a platform company developing innovative technologies to overcome the barriers of nucleic acid delivery, today announced a multi-year partnership with Novo Nordisk to advance ...
Keywords: Non-canonical Nucleic acids, G-quadruplexes, Expandable repeats, Gene expression, R-loops Important Note: All contributions to this Research Topic must be within the scope of the section and ...
Thanks to a serendipitous discovery and a lot of painstaking work, scientists can now build biohybrid molecules that combine the homing powers of DNA with the broad functional repertoire of proteins - ...
STONY BROOK, NY / / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in PCR-based DNA technologies, today announced it has received a follow-on ...
Having serviced this customer with multiple gram-scale orders over nearly a decade, we believe we are well positioned to meet the diagnostic industry's growing need for DNA and expand our IVD customer ...
Understanding protein function within living cells is crucial for basic research and therapeutic development. Protein kinetics in living cells provide more relevant insights compared to studies in ...